A critical review of the efficacy and safety in the use of low-molecular-weight heparin in acute ST-elevation myocardial infarction: a Bayesan approach

E Buccelletti; C Spadaccio; M Chello; Davide Marsiliani; Annarita Carroccia; P Iacomini; G Calabrò; Nicolo' Gentiloni Silveri; Francesco Franceschi

A critical review of the efficacy and safety in the use of low-molecular-weight heparin in acute ST-elevation myocardial infarction: a Bayesan approach

E Buccelletti, C Spadaccio, M Chello, Davide Marsiliani, Annarita Carroccia, P Iacomini, G Calabrò, Nicolo' Gentiloni Silveri, Francesco Franceschi

Research output: Contribution to journal › Article

Abstract

ST segment elevation myocardial infarction (STEMI) is an important risk factor of death worldwide. Significant clinical research has been done to assess ideal reperfusion strategies in the setting of STEMI, including the role of the antithrombin agents: unfractionated heparin (UFH) and low molecular weight heparin (LMWH). Given the evidence that LMWH may be safer than UFH in the treatment of other thrombotic disorders, its role in the management of STEMI needs to be more defined.

Original language	English
Pages (from-to)	701-710
Number of pages	10
Journal	European Review for Medical and Pharmacological Sciences
Volume	15
Publication status	Published - 2011

Keywords

Anticoagulants
Bayes Theorem
Hemorrhage
Heparin, Low-Molecular-Weight
Humans
Models, Statistical
Myocardial Infarction
Randomized Controlled Trials as Topic

Cite this

Buccelletti, E., Spadaccio, C., Chello, M., Marsiliani, D., Carroccia, A., Iacomini, P., Calabrò, G., Gentiloni Silveri, N., & Franceschi, F. (2011). A critical review of the efficacy and safety in the use of low-molecular-weight heparin in acute ST-elevation myocardial infarction: a Bayesan approach. European Review for Medical and Pharmacological Sciences, 15, 701-710.

@article{cc1263f18a3e4918b411e726beddec03,

title = "A critical review of the efficacy and safety in the use of low-molecular-weight heparin in acute ST-elevation myocardial infarction: a Bayesan approach",

abstract = "ST segment elevation myocardial infarction (STEMI) is an important risk factor of death worldwide. Significant clinical research has been done to assess ideal reperfusion strategies in the setting of STEMI, including the role of the antithrombin agents: unfractionated heparin (UFH) and low molecular weight heparin (LMWH). Given the evidence that LMWH may be safer than UFH in the treatment of other thrombotic disorders, its role in the management of STEMI needs to be more defined.",

keywords = "Anticoagulants, Bayes Theorem, Hemorrhage, Heparin, Low-Molecular-Weight, Humans, Models, Statistical, Myocardial Infarction, Randomized Controlled Trials as Topic, Anticoagulants, Bayes Theorem, Hemorrhage, Heparin, Low-Molecular-Weight, Humans, Models, Statistical, Myocardial Infarction, Randomized Controlled Trials as Topic",

author = "E Buccelletti and C Spadaccio and M Chello and Davide Marsiliani and Annarita Carroccia and P Iacomini and G Calabr{\`o} and {Gentiloni Silveri}, Nicolo' and Francesco Franceschi",

year = "2011",

language = "English",

volume = "15",

pages = "701--710",

journal = "European Review for Medical and Pharmacological Sciences",

issn = "1128-3602",

publisher = "Roma: Verduci publisher.",

}

Buccelletti, E, Spadaccio, C, Chello, M, Marsiliani, D, Carroccia, A, Iacomini, P, Calabrò, G, Gentiloni Silveri, N & Franceschi, F 2011, 'A critical review of the efficacy and safety in the use of low-molecular-weight heparin in acute ST-elevation myocardial infarction: a Bayesan approach', European Review for Medical and Pharmacological Sciences, vol. 15, pp. 701-710.

TY - JOUR

T1 - A critical review of the efficacy and safety in the use of low-molecular-weight heparin in acute ST-elevation myocardial infarction: a Bayesan approach

AU - Buccelletti, E

AU - Spadaccio, C

AU - Chello, M

AU - Marsiliani, Davide

AU - Carroccia, Annarita

AU - Iacomini, P

AU - Calabrò, G

AU - Gentiloni Silveri, Nicolo'

AU - Franceschi, Francesco

PY - 2011

Y1 - 2011

N2 - ST segment elevation myocardial infarction (STEMI) is an important risk factor of death worldwide. Significant clinical research has been done to assess ideal reperfusion strategies in the setting of STEMI, including the role of the antithrombin agents: unfractionated heparin (UFH) and low molecular weight heparin (LMWH). Given the evidence that LMWH may be safer than UFH in the treatment of other thrombotic disorders, its role in the management of STEMI needs to be more defined.

AB - ST segment elevation myocardial infarction (STEMI) is an important risk factor of death worldwide. Significant clinical research has been done to assess ideal reperfusion strategies in the setting of STEMI, including the role of the antithrombin agents: unfractionated heparin (UFH) and low molecular weight heparin (LMWH). Given the evidence that LMWH may be safer than UFH in the treatment of other thrombotic disorders, its role in the management of STEMI needs to be more defined.

KW - Anticoagulants

KW - Bayes Theorem

KW - Hemorrhage

KW - Heparin, Low-Molecular-Weight

KW - Humans

KW - Models, Statistical

KW - Myocardial Infarction

KW - Randomized Controlled Trials as Topic

KW - Anticoagulants

KW - Bayes Theorem

KW - Hemorrhage

KW - Heparin, Low-Molecular-Weight

KW - Humans

KW - Models, Statistical

KW - Myocardial Infarction

KW - Randomized Controlled Trials as Topic

UR - http://hdl.handle.net/10807/12840

UR - http://www.europeanreview.org/article/965

M3 - Article

SN - 1128-3602

VL - 15

SP - 701

EP - 710

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

ER -

A critical review of the efficacy and safety in the use of low-molecular-weight heparin in acute ST-elevation myocardial infarction: a Bayesan approach

Abstract

Keywords

Other files and links

Fingerprint

Cite this